Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lin-Lin Liu, Jing-Hui Hu, Jing-Jing Pan, Hong Liu, Fu-Hai Ji & Ke Peng. (2023) An Intraoperative Sub-Anesthetic Dose of Esketamine on Postoperative Depressive Symptoms in Perimenopausal Women with Breast Cancer Undergoing Modified Radical Mastectomy: Protocol for a Randomized, Triple-Blinded, Controlled Trial. International Journal of General Medicine 16, pages 3373-3381.
Read now
Read now
Articles from other publishers (19)
Ming Jiang, Qianqian Li, Mingjie Mao, Chenyang Xu, Rongrong Zhou, Yazhou Wen, Hongmei Yuan & Shanwu Feng. (2023) Evaluation of clinical effects of Esketamine on depression in patients with missed miscarriage: A randomized, controlled, double-blind trial. Journal of Affective Disorders 329, pages 525-530.
Crossref
Crossref
Julie M. Deleemans, Haley Mather, Athina Spiropoulos, Kirsti Toivonen, Mohamad Baydoun & Linda E. Carlson. (2023) Recent Progress in Mind–Body Therapies in Cancer Care. Current Oncology Reports 25:4, pages 293-307.
Crossref
Crossref
Giovanni Vita, Beatrice Compri, Faith Matcham, Corrado Barbui & Giovanni Ostuzzi. (2023) Antidepressants for the treatment of depression in people with cancer. Cochrane Database of Systematic Reviews 2023:3.
Crossref
Crossref
Shu-lin Gan, Yu-qin Long, Qin-yun Wang, Chang-dong Feng, Chen-xu Lai, Chun-tong Liu, Yun-ying Ding, Hong Liu, Ke Peng & Fu-hai Ji. (2023) Effect of esketamine on postoperative depressive symptoms in patients undergoing thoracoscopic lung cancer surgery: A randomized controlled trial. Frontiers in Psychiatry 14.
Crossref
Crossref
Canye Li, Qiming Cai, Zuanjun Su, Zhicong Chen, Jinming Cao & Feng Xu. (2023) Could peripheral 5-HT level be used as a biomarker for depression diagnosis and treatment? A narrative minireview. Frontiers in Pharmacology 14.
Crossref
Crossref
Shubham Kamal, Manish Kumar Jha & Rajiv Radhakrishnan. (2023) Role of Psychedelics in Treatment-Resistant Depression. Psychiatric Clinics of North America.
Crossref
Crossref
Jing Xie, Qi Zhong, Wen-tao Wu & Jian-jun Chen. (2023) Multi-omics data reveals the important role of glycerophospholipid metabolism in the crosstalk between gut and brain in depression. Journal of Translational Medicine 21:1.
Crossref
Crossref
Zhen Zhang, Wen-Hao Zhang, Yin-Xiao Lu, Bo-Xuan Lu, Yi-Bo Wang, Li-Ying Cui, Hao Cheng, Zhen-Yu Yuan, Jie Zhang, Da-Peng Gao, Jian-Feng Gong & Qing Ji. (2023) Intraoperative Low-Dose S-Ketamine Reduces Depressive Symptoms in Patients with Crohn’s Disease Undergoing Bowel Resection: A Randomized Controlled Trial. Journal of Clinical Medicine 12:3, pages 1152.
Crossref
Crossref
Jie Guo, Di Qiu, Han-wen Gu, Xing-ming Wang, Kenji Hashimoto, Guang-fen Zhang & Jian-jun Yang. (2023) Efficacy and safety of perioperative application of ketamine on postoperative depression: A meta-analysis of randomized controlled studies. Molecular Psychiatry.
Crossref
Crossref
Ju Tang, Zhiguo Zheng, Qijun Ran, Feng Zhao, Yao Wang, Feng Hu, Chao Yang & Xiaoyong Tan. (2023) Epidural esketamine and morphine for postoperative analgesia after caesarean delivery: A pilot study. Frontiers in Surgery 9.
Crossref
Crossref
Aksharra Balachandran, Vanessa K. Tassone, Fathima Adamsahib, Anne-Marie Di Passa, Sarah Kuburi, Ilya Demchenko, Karim S. Ladha & Venkat Bhat. (2022) Efficacy of ketamine for comorbid depression and acute or chronic pain: A systematic review. Frontiers in Pain Research 3.
Crossref
Crossref
Xiang Cheng, Han Wang, Mengmeng Diao & Hao Jiao. (2022) Effect of S-ketamine on Postoperative Quality of Recovery in Patients Undergoing Video-Assisted Thoracic Surgery. Journal of Cardiothoracic and Vascular Anesthesia 36:8, pages 3049-3056.
Crossref
Crossref
Sanne Y Smith-Apeldoorn, Maurice Vischjager, Jolien KE Veraart, Jeanine Kamphuis, Marije aan het Rot & Robert A Schoevers. (2022) The antidepressant effect and safety of non-intranasal esketamine: A systematic review. Journal of Psychopharmacology 36:5, pages 531-544.
Crossref
Crossref
Jing Wang, Yi Sun, Pan Ai, Victoria Cui, Hui Shi, Dongjiao An, Anshi Wu & Changwei Wei. (2022) The effect of intravenous ketamine on depressive symptoms after surgery: A systematic review. Journal of Clinical Anesthesia 77, pages 110631.
Crossref
Crossref
Xiao‐Xi Zhang, Nai‐Xin Zhang, De‐Xing Liu, Jun Ding, Yi‐Nan Zhang & Zhao‐Qiong Zhu. (2022) Research advances in the clinical application of esketamine. Ibrain 8:1, pages 55-67.
Crossref
Crossref
Nina Schimmers, Joost J. Breeksema, Sanne Y. Smith-Apeldoorn, Jolien Veraart, Wim van den Brink & Robert A. Schoevers. (2021) Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review. Psychopharmacology 239:1, pages 15-33.
Crossref
Crossref
Hong Wang, Chong-Yang Duan, Wen-Qi Huang, Ping Zhao, Li-Zhi Zhou, Yan-Hong Liu, Cun-Ming Liu, Hai-Chen Chu, Qiang Wang, Yu-Gang Diao, Zhen Hua, Qing-Tao Meng, Hao Li, Xiao-Ying Zhang, Wei-Dong Mi & Ping-Yan Chen. (2021) Perioperative intravenous S(+)-ketamine for acute postoperative pain in
adults: study protocol for a multicentre, randomised, open-label,
positive-controlled, pragmatic clinical trial (SAFE-SK-A trial). BMJ Open 11:12, pages e054681.
Crossref
Crossref
Paul F. White. (2021) Ketamine and depression: An old drug in search of a clinical indication. Journal of Clinical Anesthesia 75, pages 110500.
Crossref
Crossref
Liwei Pang, Meiying Cui, Wanling Dai, Jing Kong, Hongzhi Chen & Shuodong Wu. (2020) Can Intraoperative Low-Dose R,S-Ketamine Prevent Depressive Symptoms After Surgery? The First Meta-Analysis of Clinical Trials. Frontiers in Pharmacology 11.
Crossref
Crossref